Byonyks X1: a New, Small, Portable APD Machine
Developed in Pakistan with U.S. R&D, an FDA application for the X1 was filed in Nov., 2023. Byonyks expects the X1 to be in patients’ homes in 2025. Later, the X2 and X3 will provide PD using ultrapure dialysate made on demand, which will reduce supply storage and delivery costs, as well as medical waste. Watch the 9-minute pitch video.
Read the full article » | Posted 06-14-2024
Related Articles
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
- FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026

